Greenwich LifeSciences
GLSI
42 hedge funds and large institutions have $13.3M invested in Greenwich LifeSciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
8% more funds holding
Funds holding: 39 → 42 (+3)
0.31% more ownership
Funds ownership: 8.67% → 8.98% (+0.31%)
19% less capital invested
Capital invested by funds: $16.4M → $13.3M (-$3.13M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$202K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$173K |
| 3 |
BlackRock
New York
|
+$103K |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
+$77.6K |
| 5 |
JP Morgan Chase
New York
|
+$59.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$153K |
| 2 |
Renaissance Technologies
New York
|
-$131K |
| 3 |
Morgan Stanley
New York
|
-$43.6K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.94K |
| 5 |
CF
Corebridge Financial
Houston,
Texas
|
-$2.17K |
GLSI Hedge Fund Activity: Q4 2024 in Review
42 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2024, worth a combined $13.3M — down 19% from $16.4M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new GLSI positions and 3 closed out — a net gain of 3 holders — while 16 added to existing stakes and 6 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $202K. The largest seller was Millennium Management, exiting entirely with an estimated $153K sold.
- 42 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2024, up from 39 in Q3 2024.
- Funds reported $13.3M of Greenwich LifeSciences stock for Q4 2024, down 19% quarter-over-quarter.
- 6 funds opened new Greenwich LifeSciences positions in Q4 2024 and 3 closed out, a net change of +3 holders.
- The largest Greenwich LifeSciences buyer in Q4 2024 was Goldman Sachs, an estimated $202K added.
- The largest Greenwich LifeSciences seller in Q4 2024 was Millennium Management, an estimated $153K sold.
Based on aggregated 13F filings for Q4 2024.